Platelets and the new comprehension of haemostasis;Die zentrale rolle der thrombozyten im neuen verständnis der hämostase

Hamostaseologie

Volumn 25, Issue 1, 2005, Pages 39-49

  Jurk, K ^a   Kehrel, B E ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Host defence; Inflammation; Platelets; Thrombin generation

Indexed keywords

ANTIBIOTIC AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BETA LYSIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; CTAP 3 PEPTIDE; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; MATRIX PROTEIN; NAP 2 PEPTIDE; PROTEASE NEXIN; PROTEASE NEXIN 2; PROTHROMBIN; RANTES; THROMBIN; THROMBIN INHIBITOR; THROMBOCIDINE; THROMBOCYTE FACTOR 4; THROMBOPLASTIN; THYMOSIN BETA4; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

AUTOREGULATION; BINDING AFFINITY; BLOOD CLOTTING; BLOOD VESSEL INJURY; CONFERENCE PAPER; FIBRIN CLOT; HEMOSTASIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE; NONHUMAN; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBUS; VENOUS THROMBOEMBOLISM;

EID: 14344256853     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619643     Document Type: Conference Paper

References (97)

1. Ahmad R, Menezes J, Knafo L et al. Activated human platelets express Fas-L and induce apoptosis in Fas-positive tumor cells. J Leukoc Biol 2001; 69: 123-8.
2. Ahmad SS, Rawala-Sheikh R, Walsh PN. Comparative interactions of factor IX and factor IXa with human platelets. J Biol Chem 1989; 264: 3244-51.
3. Ahmad SS, Rawala-Sheikh R, Cheung WF et al. High-affinity, specific factor IXa binding to platelets is mediated in part by residues 3-11. Biochemistry 1994; 33: 12048-55.
4. Ahmad SS, Scandura JM, Walsh PN. Structural and functional characterization of platelet receptor-mediated factor VIII binding. J Biol Chem 2000; 275: 13071-81.
5. Ahmad SS, Walsh PN. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface. Biochemistry 2002; 41: 11269-76.
6. Akbiyik F, Ray DM, Gettings KF et al. Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. Blood 2004; 104: 1361-8.
7. Andre P, Prasad KS, Denis CV et al. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 2002; 8: 247-52.
8. Auger JM, Best D, Snell DC et al. c-Cbl negatively regulates platelet activation by glycoprotein VI. J Thromb Haemost 2003; 1: 2419-26.
9. Aukrust P, Muller F, Ueland T et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999; 100: 614-20.
10. Baglia FA, Shrimpton CN, Lopez JA et al. The glycoprotein Ib-IX-V complex mediates localization of factor XI to lipid rafts on the platelet membrane. J Biol Chem 2003; 278: 21744-50.
11. Baglia FA, Shrimpton CN, Emsley J et al. Factor XI interacts with the leucine-rich repeats of glycoprotein Ibalpha on the activated platelet. J Biol Chem 2004; 279: 49323-9
12. Baglia FA, Gailani D, Lopez JA et al. Identificatíon of a binding site for glycoprotein Ibalpha in the apple 3 domain of factor XI. J Biol Chem 2004; 279: 45470-6.
13. BairdTR, Walsh PN. The interaction of factor XIa with activated platelets but not endothelial cells promotes the activation of factor IX in the consolidation phase of blood coagulation. J Biol Chem 2002; 277: 38462-7.
14. Barry OP, Pratico D, Savani RC et al. Modulation of monocyte-endothelial cell interactions by pletelet microparticles. J Clin Invest 1998; 102; 136-44.
15. Bergmeier W, Piffath CL, Cheng G et al. Tumor necrosis factor-alpha-converting enzyme (ADAM 17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res 2004; 95: 677-83.
16. Bergmeier W, Rabie T, Strehl A, et al. GPVI downregulation in murine platelets through metalloproteinase-dependent shedding. Thromb Haemost 2004; 91: 951-8.
17. Bouchard BA, Catcher CS, Thrash BR et al. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. J Biol Chem 1997; 272: 9244-51.
18. Brain SD. Sensory neuropeptides: their role in inflammation and wound healing. Immunopharmacology 1997; 37: 133-52.
19. Brass LF. Thrombin and platelet activation. Chest 2003;124:18S-25S.
20. Brodde MF, Horn M, Níemann S et al. New link between inflammation and haemostasis - alpha defensins (HNP-1/2) are strong platelet agonists. Hämostaseologie 2004; 1: V65.
21. Broze GJ Jr, Miletich JP. Characterization of the inhibition of tissue factor in serum. Blood 1987; 69: 150-5.
22. Bukharin OV, Suleimanov KG. The role of the thrombocytic cationic protein (beta-lysin) in anti-infectious protection. Zh Mikrobiol Epidemiol Immunobiol 1997; 3-6.
23. Chromek M, Tullus K, Lundahl J et al. Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation. Infect Immun 2004; 72: 82-8.
24. Clawson CC, White JG. Platelet interaction with bacteria. II. Fate of the bacteria. Am J Pathol 1971; 65: 381-97.
25. Clemetson JM, Polgar J, Magnenat E et al. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 1999; 274: 29019-24.
26. Clemetson KJ, Clemetson JM. Platelet GPIb-V-IX complex. Structure, function, physiology, and pathology. Semin Thromb Hemost 1995; 21: 130-6.
27. Coppinger JA, Cagney G, Toomey S et al. Charac-terization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004; 103: 2096-104.
28. Crombie R, Silverstein RL, MacLow C et al. Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. J Exp Med 1998; 187: 25-35.
29. Dale GL, Friese P, Batar P et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002; 415: 175-9.
30. Danese S, de la MC, Reyes BM et al. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J Immunol 2004; 172: 2011-5.
31. Diacovo TG, de Fougerolles AR, Bainton DF et al. A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2. J Clin Invest 1994; 94: 1243-51.
32. Dormann D, Clemetson KJ, Kehrel BE. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000; 96: 2469-78.
33. Dorsam RT, Kunapuli SP. Central role of the P2Y( 12) receptor in platelet activation. J Clin Invest 2004; 113: 340-5.
34. Elzey BD, Tian J, Jensen RJ et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 2003; 19: 9-19.
35. Fabre JE, Nguyen M, Latour A et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999; 5: 1199-202.
36. Fernandez-Patron C, Martinez-Cuesta MA, Salas E et al. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb Haemost 1999; 82: 1730-5.
37. Fowler VG Jr, McIntyre LM, Yeaman MR et al. In vitro resistance to thrombin-induced platelet microbicidal protein in isolates of Staphylococcus aureus from endocarditis patients correlates with an intravascular device source. J Infect Dis 2000; 182: 1251-4.
38. Frenette PS, Denis CV, Weiss L et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000; 191: 1413-22.
39. Furie B, Furie BC, Flaumenhaft R. A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 2001; 86: 214-21.
40. Furman MI, Barnard MR, Krueger LA et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001; 38: 1002-6.
41. Gabriel DA, Li X, Monroe DM III et al. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets. J Thromb Haemost 2004; 2: 1816-22.
42. Garlichs CD, Kozina S, Fateh-Moghadam S et al. Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke 2003; 34: 1412-8.
43. Gear AR, Camerini D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 2003; 10: 335-50.
44. Gecse A, Kis B, Mezei Z et al. Effects of inflammatory neuropeptides on the arachidonate cascade of platelets. Int Arch Allergy Immunol 1999; 118: 166-70.
45. Gibbins JM. The negative regulation of platelet function: extending the role of the ITIM. Trends Cardiovasc Med 2002; 12: 213-9.
46. Graham GJ, Stevens JM, Page NM et al. Tachykinins regulate the function of platelets. Blood 2004; 104: 1058-65.
47. Haque A, Cuna W, Bonnel B et al. Platelet mediated killing of larvae from different filarial species in the presence of Dipetalonema viteae stimulated IgE antibodies. Parasite Immunol 1985; 7: 517-26.
48. Hartwell DW, MayadasTN, Berger G et al. Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses. J Cell Biol 1998; 143: 1129-41.
49. Henn V, Slupsky JR, Grafe M et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591-4.
50. Hoffman M, Monroe DM, Roberts HR. Platelet-dependent action of high-dose factor VIIa. Blood 2002; 100: 364-5.
51. Holme PA, Orvim U, Hamers MJ et al. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 1997; 17: 646-53.
52. Hubbard AR, Jennings CA. Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins. Thromb Res 1987; 46: 527-37.
53. Jurk K, Clemetson KJ, de Groot PG et al. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor. FASEB J 2003; 17: 1490-2.
54. Jurk K, Strey A, Janning A et al. Platelets associated with monocytes modulate monocytic extravasation. Hämostaseologie 2004; 1: P70.
55. Kalvegren H, Majeed M, Bengtsson T. Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: a causal role in cardiovascular disease? Arterioscler Thromb Vasc Biol 2003; 23: 1677-83.
56. Kehrel B, Balleisen L, Kokott R et al. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 1988; 71: 1074-8.
57. Kehrel B. Platelet-collagen interactions. Semin Thromb Hemost 1995; 21: 123-9.
58. Kehrel B, Wierwille S, Clemetson KJ et al. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood 1998; 91: 491-9.
59. Kerrigan SW, Douglas I, Wray A et al. A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. Blood 2002; 100: 509-16.
60. Krijgsveld J, Zaat SA, Meeldijk J et al. Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem 2000; 275: 20374-81.
61. Kuijper PH, Gallardo Torres HI, Houben LA et al. P-selectin and MAC-1 mediate monocyte rolling and adhesion to ECM-bound platelets under flow conditions. J Leukoc Biol 1998; 64: 467-73.
62. Lahav J, Jurk K, Hess O et al. Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood 2002; 100: 2472-8.
63. Levin J. The evolution of mammalian platelets. In: Michelson AD (ed). Platelets. San Diego: Academic Press 2000: 3-19.
64. Lewis JC, Maldonado JE, Mann KG. Phagocytosis in human platelets: localization of acid phosphatase-positive phagosomes following latex uptake. Blood 1976; 47: 833-40.
65. London FS, Marcinkiewicz M, Walsh PN. A subpopulation of platelets responds to thrombin- or SFLLRN-stimulation with binding sites for factor IXa. J Biol Chem 2004; 279: 19854-9.
66. Lourbakos A, Yuan YP, Jenkins AL et al. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood 2001; 97: 3790-7.
67. Luscher EF, Weber S. The formation of the haemostatic plug - a special case of platelet aggregation. An experiment and a survey of the literature. Thromb Haemost 1993; 70: 234-7.
68. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002; 22: 1381-9.
69. Morrissey JH. Tissue factor and factor VIII initiation of coagulation. In: Colman RW, Hirsh J, Marder VJ et al. (eds). Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: Lippincott, Wiliams and Wilkins 2001: 89-102.
70. Nesheim ME, Furmaniak-Kazmierczak E, Henin C et al. On the existence of platelet receptors for factor V(a) and factor VIII(a). Thromb Haemost 1993; 70: 80-6.
71. Newton-Nash DK, Newman PJ. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J Immunol 1999; 163: 682-8.
72. Niemann S, Spehr N, van Aken H et al. Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets. Circulation 2004; 110: 193-200.
73. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997; 96: 3534-41.
74. Nofer JR, Herminghaus G, Brodde M et al. Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease). J Biol Chem 2004; 279: 34032-7.
75. 0'Brien L, Kerrigan SW, Kaw G et al. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol 2002; 44: 1033-44.
76. Oliver JA, Monroe DM, Roberts HR et al. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 1999; 19: 170-7.
77. Rao AK. Congenital disorders of platelet function: disorders of signal transduction and secretion. Am J Med Sci 1998; 316: 69-76.
78. Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost 1993; 70: 119-23.
79. Scandura JM, Ahmad SS, Walsh PN. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin. Biochemistry 1996; 35: 8890-902.
80. Scandura JM, Zhang Y, van Nostrand WE et al. Progress curve analysis of the kinetics with which blood coagulation factor XIa is inhibited by protease nexin-2. Biochemistry 1997; 36: 412-20.
81. Sidhu JS, Cowan D, Kaski JC. Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus. Am J Cardiol 2004; 94: 151-6.
82. Spycher MO, Nydegger UE. Participation of the blood platelet in immune reactions due to platelet-complement interaction. Infusionsther Transfusionsmed 1995; 22: 36-43.
83. Stephens G, Yan Y, Jandrot-Perrus M et al. Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen. Blood 2004; in press.
84. Szasz R, Dale GL. Thrombospondin and fibrinogen bind serotonin- derivatized proteins on COAT-platelets. Blood 2002; 100: 2827-31.
85. Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun 2002; 70: 6524-33.
86. Tschoepe D, Rauch U, Schwippert B. Platelet-leukocyte-cross-talk in diabetes mellitus. Horm Metab Res 1997; 29: 631-5.
87. Von Hundelshausen P, Koenen RR, Sack M et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 2004; in press.
88. Wallaschofski H, Kobsar A, Koksch M et al. Prolactin receptor signaling during platelet activation. Horm Metab Res 2003; 35: 228-35.
89. Walsh PN. Platelet coagulation-protein interactions. Semin Thromb Hemost 2004; 30: 461-71.
90. Walther DJ, Peter JU, Winter S et al. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell 2003; 115: 851-62.
91. Washington AV, Schubert RL, Quigley L, et al. TREM Family Member, TLT-1, Is Found Exclusively in the {alpha}-granules of Megakaryocytes and Platelets. Blood 2004; 104: 1042-7.
92. Weyrich AS, Prescott SM, Zimmerman GA. Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. Circulation 2002; 106: 1433-5.
93. Wilkinson FH, Ahmad SS, Walsh PN. The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex. J Biol Chem 2002; 277: 5734-41.
94. Yang X, Chang YJ, Lin SW et al. Identification of residues Asn 89, Ile 90 and Val 107 of the factor IXa second epidermal growth factor domain that are essential for the assembly of the factor X activating complex on activated platelets. J Biol Chem 2004; 279: 46400-5.
95. Yeaman MR. The role of platelets in antimicrobial host defense. Clin Infect Dis 1997; 25: 951-68.
96. Zimmerman GA, McIntyre TM, Prescott SM et al. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 2002; 30: S294-301.
97. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12: 121-7.